ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.
ŌURA, which was founded in Finland in 2013, offers a wearable smart…
Continue Reading
This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor.
The company added generative AI to its Stelo glucose monitor, which it began selling four months ago….
Continue Reading
Health-tracking ring maker Oura announced it closed a $200 million Series D funding round led by Fidelity Management & Research Company and Dexcom. The investment raises the company’s valuation to $5.2 billion.WHAT IT DOES
The…
What You Should Know:
– ŌURA, the company behind the world’s leading smart ring, has announced the completion of a $200 million Series D funding round, raising its valuation to $5.2B.
– This significant investment, with…
Continue Reading
What You Should Know:
– Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
– The Stelo platform…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– In-warranty users can now integrate their pumps with both the Dexcom…
Continue Reading
Introduction
Dexcom, a leader in continuous glucose monitoring (CGM) technology, has revolutionized diabetes management and ventured into broader health and wellness applications. With over 25 years of innovation, the company is forging partnerships and expanding…
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7’s expanded capabilities to connect directly to the Apple Watch and, most recently,…
Continue Reading
Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s continuous glucose monitor (CGM) and…
Continue Reading
What You Should Know:
– DexCom, the global leader in continuous glucose monitoring (CGM), and ŌURA, the maker of the leading smart ring, have announced a strategic partnership to help millions of people improve their…
Continue Reading
